MIT develops new paper-based Zika virus test

MIT researchers have led a team in developing a paper-based test that can diagnose the Zika virus in just a few hours.  Read More »

Study shows Zika can be transmitted through sexual contact

A study has confirmed that the Zika virus, known to wreak havoc while masked by mild or no symptoms, can be transmitted not only through bites from infected Aedes mosquito but also via sexual contact. Read More »

Researchers study progression of HIV during early stages of infection

Research from several collaborating laboratories, initiated through the Consortium for AIDS Vaccine Research, examined monkeys exposed to Simian Immunovirus infection to determine what happens during the earliest stages of HIV infection in humans. Read More »

Study finds resistance to CRISPR/Cas9 platform when used to target HIV

A recently published study found that the CRISPR/Cas9 gene-editing platform can inhibit viral replication through single mutations, but that viruses that escape the targeted approach become more difficult to target. Read More »

Study shows ethnicity may affect response to flu vaccine

A recent study conducted at the Dana-Farber Cancer Institute shows that the immune response generated by the influenza vaccine may be linked to a person’s ethnic background and similar inherited variables. Read More »

VBI partners with GSK to improve vaccine stability

VBI Vaccines Inc. and GlaxoSmithKline (GSK) Biologicals recently made a partnership to determine how to best improve vaccine stability with VBI’s LPV Platform. Read More »

Harvard Medical School, Children's Hospital investigate effects of initial influenza infection

Harvard Medical School, together with Children’s Hospital, is at work on research that could indicate lasting effects left by the initial incidence of an influenza infection. Read More »

Massachusetts Medical School identifies new stage of HIV infection

University of Massachusetts Medical School (UMMS) scientists recently detected a new life-cycle stage that is part of HIV infections. Read More »

Scientists detect why influenza vaccines are less effective for seniors

A recent study from researchers at the University of California San Diego (UCSD) and Emory University shows why the influenza vaccine is not as effective in protecting elderly people from contracting the virus. Read More »

Multiple TB strains discovered in Ethiopia

Health professionals recently discovered a wide variety of diverse strains of tuberculosis (TB) in Ethiopia. Read More »

Harvard team discovers new ways to study viruses

Researchers from Harvard University’s John A Paulson School of Engineering and Applied Sciences have found new ways to study viruses, which may help to create better treatments and vaccines. Read More »

Humans, apes share genes connected to malaria virulence

Scientists from the Harvard TH Chan School of Public Health recently found that malaria parasite molecules share important gene segments with gorilla and chimp malaria parasites. Read More »

Visterra receives contract to develop new treatment for influenza A

Visterra, Inc. has recently received a contract worth up to $204.5 million to further develop its new monoclonal antibody to treat influenza A. Read More »

Alere redoubles efforts with Organization of African First Ladies Against HIV/AIDS

Alere said this week that it is redoubling its commitment to support the Organization of African First Ladies Against HIV/AIDS (OAFLA). Alere, a global leader in rapid diagnostics, aims to help reduce the impact of HIV/AIDS in Africa, specifically mother-to-child transmission. Read More »

Study: Type 1 diabetes may transform intestinal lining

Up to 80 percent of patients with type 1 diabetes develop diabetic enteropathy, a set of gastrointestinal symptoms that include irritable bowel syndrome, abdominal distension and fecal incontinence, and a recent study suggests that the disease may actual alter the intestines' structure. Read More »

Scientists reveal how the flu spreads

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and MIT have discovered how the flu virus and its many strains, some of which are more capable of spreading than others, manage to transmit from person to person. Read More »

Agenus Inc. finalizes transaction terms with Oberland Capital

Agenus Inc., an immunology company that discovers and creates novel treatments for diseases like cancer, recently announced that it has finalized its non-dilutive royalty transactions pursuant to a note purchase agreement with Oberland Capital Management LLC, the leader of the investor group. Read More »

Mobile phone records may predict dengue fever epidemics

Harvard T.H. Chan School of Public Health said Monday that its researchers found that mobile phone records may be useful in predicting and timing the geographical spread of dengue fever epidemics. Read More »

VBI Vaccines receives grant to advance RSV candidate

VBI Vaccines Inc. recently received approximately $265,000 in grants to further develop the company’s eVLP Platform, which will be used to create a respiratory syncytial virus (RSV) vaccine candidate. Read More »

Doctors overestimate their Ebola assessment abilities

A recent survey of primary care physicians show that many of them overestimate their own abilities to assess potential Ebola cases and explain the risks of Ebola to their patients. Read More »